Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Office of the Revisor of Statutes

2024 Minnesota Session Laws Index (topics)

DRUGS AND MEDICINE

340B Drug Pricing Program, reports, Minn. Law 2024 c 127 art 59 s 2, 57

Authority to prescribe, dispense, and administer

Midwives, Minn. Law 2024 c 77 s 2

School personnel, Minn. Law 2024 c 109 art 8 s 5 to 2024 c 109 art 8 s 7

Cannabinoid products

Registration, Minn. Law 2024 c 121 art 2 s 9

Sales, testing, labeling, Minn. Law 2024 c 121 art 2 s 6 to 2024 c 121 art 2 s 8, 10, 11

Controlled substances, see CONTROLLED SUBSTANCES

Epinephrine, auto-injectors, school personnel authorized to administer, Minn. Law 2024 c 109 art 8 s 7

HIV prevention drugs, Minn. Law 2024 c 127 art 60 s 11

Insulin

Insulin manufacturers, registration fees, Minn. Law 2024 c 127 art 56 s 6

Safety net program, Minn. Law 2024 c 127 art 56 s 7, 8

Labels and labeling

Accessible labels

Assessment, Minn. Law 2024 c 127 art 60 s 24

Notice to consumer, Minn. Law 2024 c 127 art 60 s 10

Plain language, Minn. Law 2024 c 127 art 60 s 25

Cannabinoid products, Minn. Law 2024 c 121 art 2 s 8

Legend drugs, dispensing, Minn. Law 2024 c 77 s 2

Manufacturers

340B Drug Pricing Program, prohibited activity, Minn. Law 2024 c 121 art 4 s 3

Insulin manufacturers, registration fees, Minn. Law 2024 c 127 art 56 s 6

Reimbursement, insulin safety net program, Minn. Law 2024 c 127 art 56 s 4 to 2024 c 127 art 56 s 6

Medical marijuana, see MEDICAL CANNABIS

Opioids and opiates, see under CONTROLLED SUBSTANCES

Packages and packaging, cannabinoid products, Minn. Law 2024 c 121 art 2 s 8

Prescription drugs

340B Drug Pricing Program

Access to drugs, Minn. Law 2024 c 121 art 4 s 3

Reports, Minn. Law 2024 c 127 art 59 s 2, 57

Cost containment, 340B Drug Pricing Program, Minn. Law 2024 c 127 art 59 s 2

Medical assistance, Minn. Law 2024 c 127 art 54 s 6, 7, 2024 c 127 art 55 s 9

Medication repository program, Minn. Law 2024 c 127 art 60 s 13 to 2024 c 127 art 60 s 20

Prescription drugs of substantial public interest reporting, Minn. Law 2024 c 127 art 59 s 4

Prices, 340B Drug Pricing Program, Minn. Law 2024 c 127 art 59 s 2, 57